NCT03728673 2025-06-22
A Study Utilizing Escitalopram in Glioma Patients
University of Nebraska
Phase 2 Recruiting
Clinical Trials
12 trialsNCT04973930 2025-05-13
IPT
New York State Psychiatric Institute
Phase 3 Suspended
NCT00667121 2025-02-14
Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline
Mayo Clinic
Completed
NCT04763135 2023-06-08
MIR-P
Hospices Civils de Lyon
Phase 3 Terminated
NCT05840692 2023-05-03
The Effect of Escitalopram in PCOS
Odense University Hospital
Phase 4 Completed
NCT03010761 2019-07-24
Establishment of Cessation Therapy by Clinical Trials for Subjects With Betel-quid Dependence and Oral Pre-cancer
China Medical University Hospital
Phase 2 Terminated
NCT00352885 2018-09-14
Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment
Emory University
Phase 4 Completed
NCT02246244 2016-06-10
TADDOR
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3 Completed
NCT01961180 2016-05-09
The Effect of Cipralex on Quality of Life, Adrenal Activity Glucose Metabolism, Physical and Mental Health in PCOS
Odense University Hospital
Phase 4 Completed
NCT00621946 2014-02-04
Treatment of Outpatients With Severe Asthma and Moderate or Severe Major Depressive Disorder
University of Texas Southwestern Medical Center
Phase 4 Completed
NCT00387348 2012-12-03
Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer
Massachusetts General Hospital
Phase 3 Terminated
NCT00935675 2009-09-02
Double-blind, Placebo-controlled, Randomized Study of the Effectiveness of Escitalopram on Emotional Distress of Head and Neck Cancer Patients During Cancer Treatment
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3 Unknown